Objective: Contralateral stroke is an infrequent cause of perioperative stroke after carotid endarterectomy (CEA). Whereas the risks of ipsilateral stroke complicating CEA have been discriminated, factors that lead to contralateral stroke are poorly defined. The purpose of this study was to identify the risk of perioperative (30-day) contralateral stroke after CEA as well as predisposing preoperative and operative factors. Its specific effect on long-term survival was interrogated.
Stroke after carotid endarterectomy (CEA) has been extensively evaluated in large institutional series, administrative databases, and prospective, randomized fashion. Most strokes after CEA are ipsilateral to the carotid artery that was operated on and are related to the technical conduct of the operation. Risk factors specifically related to ipsilateral or all strokes after CEA have been discriminated. However, infrequent but real risk of contralateral stroke has historically been appreciated in 0.3% of patients in the North American Symptomatic Carotid Endarterectomy Trial (NASCET) and 0.4% of those in the Asymptomatic Carotid Atherosclerosis Study (ACAS). 1, 2 More recently, nonipsilateral stroke has been reported in the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST) and International Carotid Stenting Study (ICSS) as 0.6% and 0.2%, respectively. 3, 4 In our updated institutional series, contralateral stroke complicated 0.5% of 3014 CEAs. 5 Yet, no dedicated analysis of features associated with contralateral stroke is available. Therefore, the aim of this study was to clarify the specific risk of perioperative contralateral stroke after CEA. Furthermore, we sought to identify factors predisposing to its occurrence as well as its specific effect on long-term survival.
METHODS
A retrospective, cohort assessment of the Vascular Study Group of New England (VSGNE) regional registry data on CEA was performed. The VSGNE is a regional quality initiative developed in 2002. This registry, the oldest regional component of the Vascular Quality Initiative of the Society for Vascular Surgery, has been well described and reviewed. 6 Deidentified demographic, clinical, and procedural variables are collected on each patient at each of the participating institutions and centralized. Data are collected from the index procedure up to 1 year afterward. For this study's purposes, both the initial operative data and the initial surveillance visit were assessed. Long-term survival was estimated using VSGNE data linked to the Social Security Death Index Masterfile. Participation in this quality registry as a Patient Safety Organization and quality assurance tool for analysis was approved and direct informed consent waived by each participating center's Institutional Review Board. Specific approval for this data collection and assessment was granted after application to the VSGNE Research Advisory Committee. Recommendation: This study suggests that contralateral stroke after carotid endarterectomy is rare and is associated with longer procedures, with urgent operations, and with concomitant proximal endovascular interventions.
patients. Thirteen patients (0.1%) sustained both ipsilateral and contralateral stroke. Distribution of contralateral stroke was hemispheric in 36, vertebrobasilar in 1, ocular in 4, and unspecified in 18 cases. Stroke was recognized within 6 hours of operation in 66% of contralateral events and 75% of ipsilateral events (P ¼ .20).
Demographics, anatomy, and preoperative variables. The overwhelming majority (96%) of patients undergoing CEA in the VSGNE were white. There were no differences in cardiovascular risk factors, cardiovascular disease burden, and comorbid features between those with and those without perioperative contralateral stroke. Similarly, there were no significant differences in rates of redo carotid procedures, prior carotid intervention, irradiation, or anatomic high-risk features between the two groups. Diagnostic modalities were not associated with contralateral stroke. Those undergoing duplex ultrasound alone showed no difference in contralateral events compared with those with duplex ultrasound and other anatomic imaging (P ¼ .87). Symptomatic status did not appear to be a significant contributor to contralateral stroke manifestation (47% vs 40%; P ¼ .24). Preoperative medical therapy before CEA to include use of antiplatelet agents, statins, or antiangiotensin medications was not significantly different in those sustaining contralateral stroke. The degree of contralateral stenosis (<50%, 50%-69%, or $70%) was not a significant univariate factor in the occurrence of contralateral stroke. Contralateral occlusion was present more often in those with contralateral stroke, yet this difference did not reach significance (7% vs 3%; P ¼ .06). Significant preoperative features in those sustaining contralateral stroke included urgent operation (34% vs 17%; P ¼ .0001), stenosis of operated on internal carotid artery (<50%, 50%-69%, or $70%; P ¼ .004), cardiac stress testing (57% vs 29%; P ¼ .02), facility living status (5% vs 1%; P ¼ .03), and betablocker use (76% vs 64%; P ¼ .04). Urgent operation is defined in the VSGNE as that occurring within 24 hours of admission or when the patient is unable to be discharged before CEA (Table I) .
Operative and postoperative variables. Operative associations with contralateral stroke were related to CEA performed with other surgery. Length of operation (12% vs 4%; P ¼ .0001), CEA combined with coronary artery bypass graft (CABG; 12% vs 4%; P ¼ .0001), CEA with other open arterial surgery (7% vs 1%; P ¼ .01), and CEA with proximal endovascular intervention (5% vs 1%; P ¼ .03) were all significant factors. Other open arterial surgery includes procedures on the carotid system adjacent to the endarterectomy, such as carotid-subclavian bypass or transposition, carotid-carotid bypass, or carotid-axillary bypass. Proximal endovascular intervention is defined as balloon angioplasty or stenting of the carotid-innominate system proximal to CEA. Shunt use and techniques of CEA showed no influence on contralateral stroke. All four patients sustaining contralateral stroke with contralateral occlusion were shunted; thus, no statistical correlation was found between shunt use and contralateral stroke in those with contralateral occlusion (P ¼ .14). Use of local, regional, or general anesthesia had no effect on the occurrence of contralateral stroke. Cerebral monitoring techniques to include electroencephalography, stump pressure, and all other methods did not affect contralateral stroke risk. Of the 13 patients suffering bilateral stroke, 1 underwent CEA with proximal endovascular intervention and 2 combined CEA and CABG. Thus, these three patients accounted for 23% of bilateral stroke and 21% of contralateral stroke associated with CEA and concomitant procedures. Hypotension requiring intravenous treatment (31% vs 13%; P ¼ .00004), dysrhythmia (15% vs 2%; P ¼ .0001), return to operating room (20% vs 2%; P ¼ .0001), reperfusion syndrome (3% vs 0.2%; P ¼ .006), and hypertension requiring intravenous treatment (24% vs 13%; P ¼ .02) were postoperative factors significantly more common in those sustaining contralateral stroke (Table II) .
Logistic regression model of contralateral stroke. As noted, given the infrequency of contralateral stroke occurrence within the cohort as well as the seemingly inherent logical impact of the listed univariateassociated postoperative variables and complications, we limited regression modeling to anatomic and operative factors only for statistical fidelity and focus. Within this interaction, significant, independent drivers of contralateral stroke included operative time (OR, 1.08/ 15 minutes; 95% CI, 1.01-1.15; P ¼ .02), urgent operation (OR, 2.5; 95% CI, 1.3-4.6; P ¼ .006), and CEA with proximal endovascular intervention (OR, 8.7; 95% CI, 2.5-31.2; P ¼ .001). Operative time remained significant after removal of CEA with other procedures from the model. Other features not reaching independent significance included CEA with CABG (OR, 1.2; 95% CI, 0.3-5.3; P ¼ .81), CEA with other arterial surgery (OR, 3.4; 95% CI, 0.6-18.9; P ¼ .16), contralateral occlusion (OR, 2.0; 95% CI, 0.6-6.6; P ¼ .23), and degree of operated ipsilateral stenosis (OR, 1.8; 95% CI, 0.8-4.2; P ¼ .15). When operative time was removed from the model, neither coefficients nor P values for CEA with CABG and CEA with other arterial procedures changed. As contralateral occlusion trended toward significance, it was added to the model to determine its interplay with significant variables. The significant factors in the model remained similar with and without contralateral occlusion represented (Table III) .
Effect of contralateral stroke on late survival. There was no difference in the negative impact on 5-year survival estimates based on stroke laterality.
Contralateral (82%) and ipsilateral (67%) stroke 5-year survival rates were both significantly worse than survival in patients without perioperative stroke (86%; log-rank, P ¼ .02 and P ¼ .0005, respectively) but not different from each other (log-rank, P ¼ .24; Fig) .
DISCUSSION
Perioperative contralateral stroke after CEA occurs infrequently. Recently, randomized trials including CREST and ICSS suggested perioperative stroke contralateral to the operated on carotid artery occurring in the 0.2% to 0.6% range. 3, 4 In 2004, Mozes et al reported that in 776 carotid endarterectomies at the Mayo Clinic, contralateral stroke occurred in 0.1%. 7 In our recent institutional series describing >3000 CEAs, we found that this occurred in only 0.5%. 5 In this current report, the largest cohort assessed for contralateral perioperative stroke, the rate is identical at 0.5%. Because of rarity, there has been no dedicated evaluation of factors associated with contralateral stroke. Risk factors of perioperative stroke after CEA are well discussed. Yet, these are largely assessed in the context of ipsilateral or all strokes and death after CEA. Age, symptomatic status, female gender, diabetes, peripheral arterial disease, recurrent carotid operation, congestive heart failure, lack of antiplatelet use, plaque irregularity, operative length, urgency, closure technique, degree of ipsilateral stenosis, and contralateral occlusion have all been implicated as contributing features. 5, [7] [8] [9] [10] [11] [12] It would seem that many of these are not pertinent to risk of post-CEA contralateral stroke. Symptomatic status appears irrelevant. This is supported by the nearly identical occurrence rates in ACAS and NASCET as well as our analysis indicating no correlation. Although plaque characteristics are not evaluable within the VSGNE data, most of these other features did not prove to be independent predictors of perioperative contralateral stroke after CEA with the exception of length and urgency of operation. Antiplatelet and statin use had no impact on contralateral stroke manifestation. Contralateral stenosis and occlusion are logical foci for risk in contralateral stroke. As most operative strokes are related to ipsilateral site thromboembolism, contralateral stroke should ostensibly be related more to hemodynamic fluctuations augmenting potential for contralateral stroke. Yet, this was not the case in our study. Interestingly, contralateral occlusion specifically was not found to be predictive in this analysis of contralateral stroke, yet it is a well-recognized factor portending overall stroke risk after CEA. 5, 9, 10, 13 Admittedly, there is a trend of association on univariate analysis not borne out in regression modeling. This could be related to sample size and lack of power, leading to type II error obscuring its effects. However, the implication is that contralateral occlusion or degree of stenosis is not the predominant influence toward contralateral stroke that it would cogently seem. Also refuting hemodynamic causality, no association with shunt use or anesthetic technique was noted. Another thought-provoking aspect of this analysis of contralateral stroke after CEA is the relationship to concomitant arterial operations. The association of CEA combined with cardiac surgery or other required arterial reconstructive component with contralateral stroke risk is inherently logical. Yet, after foreseeable initial univariate significance, these failed to remain predictive in multivariate modeling for contralateral stroke. Prior evaluation within the VSGNE by Jones et al reported higher stroke rates with combined CEA and CABG compared with CEA alone.
14 However, the combined group was composed of significantly more urgent and emergent cases and naturally longer operative time. Risk of contralateral stroke with combined CEA and CABG at experienced centers can be 2% or lower. 15 Of CEA combined with CABG and other arterial procedures in this analysis, it is 1.9%, reflecting generally appropriate selection for these procedures and quality of operative care in our region. As performance of these procedures is optimized, the rare nature of contralateral stroke risk is further minimized. This infrequency of contralateral stroke with CEA, and then again also with CEA as part of other procedures, can make even large-volume assessments difficult to interpret. So, although statistically this relationship may be underpowered in this analysis to reflect increased risk, it certainly suggests that combined procedures, when done, do not prohibitively enhance contralateral stroke risk. Related and also perplexing is the statistical interaction of operative length, urgency, and operative conduct in this analysis, which seems to indicate that these are the major causative features in contralateral stroke. Only 6% of CEAs were combined with other procedures in this cohort, and when these were removed from analysis, operative length remained independently important. Specific reasons that operative time and urgency play such a consequential role in contralateral stroke independent of combined procedures are unclear. It would seem plausible that features specific to CEA not identifiable in the VSGNE, such as carotid lesion length and location and perhaps plaque instability, leading to longer operations and urgency are salient. These might reflect a more global cerebrovascular disease burden marking those at highest risk for perioperative contralateral stroke irrespective of current symptoms or selection for combined procedure. The predominant factor driving contralateral perioperative stroke risk herein is the addition of proximal endovascular intervention to CEA. Some have suggested that the addition of endovascular intervention to CEA adds minimal if any risk. 16 We have recently assessed our experience with adding proximal endovascular intervention to CEA and found a concerning 9% overall stroke risk. 17 This led us to caution the indiscriminate use of this hybrid procedure. Carotid angioplasty and stenting from a femoral approach has been criticized for increased contralateral hemispheric risk compared with CEA. 18, 19 This has largely been attributed to catheter-based manipulation in the aortic arch. It would seem plausible that this manipulation from a cervical approach could comparably increase contralateral risk. This appears substantiated. The varied anatomic distribution of contralateral stroke noted also suggests the importance of embolism from the arch as a cause. We estimated the impact of contralateral stroke on long-term survival after CEA to provide context within the brisk debate about risk profiles of carotid intervention. 3, 20 Contralateral stroke lessened survival in a way similar to ipsilateral stroke. Thus, there is no evidence in this assessment to indicate that laterality of stroke after CEA affects survival differently. This obviously has implications for comparative investigation of carotid angioplasty and stenting and CEA, as does the rarity of contralateral stroke with CEA defined here. Fig. Kaplan-Meier analysis of 5-year survival after carotid endarterectomy (CEA) in those without perioperative stroke, those suffering ipsilateral stroke, and those sustaining contralateral stroke. Survival after ipsilateral (P ¼ .0005) or contralateral (P ¼ .02) stroke was significantly worse than that without stroke. Survival rates after ipsilateral or contralateral stroke were similar (P ¼ .24).
institution-reported quality assurance tool and as such may suffer from under-reporting and misclassification of events. Only items within the quality tool could be evaluated, and perhaps other factors or uncaptured characteristics of the quality tool items contributing to contralateral stroke are not appreciated. Linking survival to the Death Index may introduce lag time and reporting bias. Finally, the rarity of contralateral stroke after CEA may lead to type II error throughout this analysis, restricting ability to identify important factors in occurrence and limiting statistical analysis. We are hopeful that larger, more granular assessments of contralateral stroke after CEA can occur. Yet, this is a specific discussion of contralateral stroke after CEA and a starting point for its further investigation.
CONCLUSIONS
Within the VSGNE, contralateral stroke after CEA is rare, affecting 0.5% of patients. Traditional risk reduction medical therapy does not affect occurrence. Degree of contralateral stenosis, including contralateral occlusion, does not predict perioperative contralateral stroke. Urgency of operation, length of operation, and performance of concomitant, ipsilateral endovascular intervention are major drivers of contralateral stroke risk with CEA. Contralateral stroke affects long-term survival similar to ipsilateral stroke after CEA. 
AUTHOR CONTRIBUTIONS

